Quantitative RNA Viral Assay for Immunosuppression in Humans of Type 1 (HIV-1) - Vietnam Registration 2401197ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Quantitative RNA Viral Assay for Immunosuppression in Humans of Type 1 (HIV-1) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2401197ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2401197ĐKLH/BYT-HTTB
000.00.04.G18-200419-0005
Theo theo phụ lục
Theo phụ lục
Technical Details
The Artus HI Virus-1 QS-RGQ Kit is an in vitro nucleic acid amplification test used to quantify the RNA of the human immunodeficiency virus type 1 (HIV-1) in the blood plasma (EDTA) of individuals. This diagnostic test uses reverse transcription polymerase chain reaction (RT-PCR) and is intended to be used on the QIAsymphony SP/AS and Rotor-gen Q devices. Samples from all subtypes A-H are used to evaluate the test. The Artus HI Virus-1 QS-RGQ Kit is used in combination with clinical manifestations and other clinical signs to predict and is used to support the evaluation of the viral response to treatment with antiretroviral therapy by measuring the change in the concentration of HIV-1 RNA in the blood plasma (EDTA) of individuals. The Artus HI Virus-1 QS-RGQ Kit is not intended to be used as an HIV screening test or as a diagnostic test for the presence of HIV.
Dates and Status
Aug 14, 2024

